These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 9763615)
1. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. Albert ML; Pearce SF; Francisco LM; Sauter B; Roy P; Silverstein RL; Bhardwaj N J Exp Med; 1998 Oct; 188(7):1359-68. PubMed ID: 9763615 [TBL] [Abstract][Full Text] [Related]
2. CD36 or alphavbeta3 and alphavbeta5 integrins are not essential for MHC class I cross-presentation of cell-associated antigen by CD8 alpha+ murine dendritic cells. Schulz O; Pennington DJ; Hodivala-Dilke K; Febbraio M; Reis e Sousa C J Immunol; 2002 Jun; 168(12):6057-65. PubMed ID: 12055214 [TBL] [Abstract][Full Text] [Related]
3. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells. Oh DS; Lee HK Autophagy; 2019 Dec; 15(12):2091-2106. PubMed ID: 30900506 [TBL] [Abstract][Full Text] [Related]
5. Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen. Labarrière N; Bretaudeau L; Gervois N; Bodinier M; Bougras G; Diez E; Lang F; Gregoire M; Jotereau F Int J Cancer; 2002 Sep; 101(3):280-6. PubMed ID: 12209980 [TBL] [Abstract][Full Text] [Related]
6. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis. Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791 [TBL] [Abstract][Full Text] [Related]
8. The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells. Akakura S; Singh S; Spataro M; Akakura R; Kim JI; Albert ML; Birge RB Exp Cell Res; 2004 Jan; 292(2):403-16. PubMed ID: 14697347 [TBL] [Abstract][Full Text] [Related]
9. CD36 is differentially expressed by CD8+ splenic dendritic cells but is not required for cross-presentation in vivo. Belz GT; Vremec D; Febbraio M; Corcoran L; Shortman K; Carbone FR; Heath WR J Immunol; 2002 Jun; 168(12):6066-70. PubMed ID: 12055215 [TBL] [Abstract][Full Text] [Related]
10. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow. Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764 [TBL] [Abstract][Full Text] [Related]
11. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Albert ML; Jegathesan M; Darnell RB Nat Immunol; 2001 Nov; 2(11):1010-7. PubMed ID: 11590405 [TBL] [Abstract][Full Text] [Related]
12. Delivery of alloantigens via apoptotic cells generates dendritic cells with an immature tolerogenic phenotype. Gleisner MA; Rosemblatt M; Fierro JA; Bono MR Transplant Proc; 2011; 43(6):2325-33. PubMed ID: 21839264 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. Harshyne LA; Watkins SC; Gambotto A; Barratt-Boyes SM J Immunol; 2001 Mar; 166(6):3717-23. PubMed ID: 11238612 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Albert ML; Sauter B; Bhardwaj N Nature; 1998 Mar; 392(6671):86-9. PubMed ID: 9510252 [TBL] [Abstract][Full Text] [Related]
15. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes. von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240 [TBL] [Abstract][Full Text] [Related]
16. Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. Blachère NE; Darnell RB; Albert ML PLoS Biol; 2005 Jun; 3(6):e185. PubMed ID: 15839733 [TBL] [Abstract][Full Text] [Related]
17. Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway. Win SJ; Ward VK; Dunbar PR; Young SL; Baird MA Immunol Cell Biol; 2011 Aug; 89(6):681-8. PubMed ID: 21221122 [TBL] [Abstract][Full Text] [Related]
18. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. Sauter B; Albert ML; Francisco L; Larsson M; Somersan S; Bhardwaj N J Exp Med; 2000 Feb; 191(3):423-34. PubMed ID: 10662788 [TBL] [Abstract][Full Text] [Related]
19. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo. Ho NI; Camps MGM; de Haas EFE; Ossendorp F Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785 [TBL] [Abstract][Full Text] [Related]
20. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. den Haan JM; Lehar SM; Bevan MJ J Exp Med; 2000 Dec; 192(12):1685-96. PubMed ID: 11120766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]